Investigational Site Number : 1560007

Beijing 100730

0 studies enrolling now · 4 studies all time

What they study most

Hemophilia, Multiple Sclerosis, Prurigo Nodularis

Studies at this site

• Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis — Running, not enrolling
• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
• Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX — Running, not enrolling
• Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study — Running, not enrolling